ContextVision – Second quarter saw commercial release of first AI-based product, Altumira™, Digital Pathology on track and record sales

STOCKHOLM – August 15, 2019 – ContextVision, a medical technology software company specializing in image analysis and artificial intelligence, continued to advance its artificial intelligence portfolio in the second quarter 2019. The company’s AI-based product Altumira™ for X-ray is now commercially available and INIFY Prostate for digital pathology will soon move to beta testing in […]
Read More

ContextVision’s Deep Learning experts will hold an oral presentation at the Medical Imaging & Deep Learning conference in London July 8–10

This paper presents an interesting and novel idea of a deep learning (DL) framework to segment potentially cancerous areas in prostate biopsies using semi-automatically generated data. The application of this paper is quite innovative and the proposed method seems to be a direct assistance to the clinical routine.
Read More

ContextVision sees strong sales, continues focus on launch of AI-based digital pathology

ContextVision, a medical technology software company specializing in image analysis and artificial intelligence, reported strong sales in Q1, reaching 21.1 MSEK, 9% higher than the first quarter last year. The company reports positive feedback from user tests within digital pathology and continues to proceed with product development for this fast-growing market.
Read More

ContextVision signs agreement for research based on unique big data cohorts

ContextVision will have exclusive rights to the scanning cohort and access to anonymized associated clinical data - with cleared and structured histopathological descriptions, diagnosis and outcome data - for the defined patient cohorts and all commercial rights from output based on the data.The agreement gives ContextVision an opportunity to create AI-based decision support tools that will help doctors make more accurate treatment decisions. Today, many cancer patients suffer from life impairing side effects from treatments they did not need while other patients do not get treatment which is necessary.
Read More

ContextVision – Fredrik Palm appointed new CEO

STOCKHOLM – 27. of March 2019 – ContextVision, a medical technology company specializing in image analysis and artificial intelligence, is pleased to announce that Fredrik Palm will become CEO of the Company as of April 1, 2019. Fredrik Palm has since 2012 been the Company’s V.P. of sales and was instrumental in growing sales significantly under his […]
Read More

ContextVision to showcase Altumira(TM), AI-powered image enhancement for digital radiography at ECR 2019

With deep learning technology integrated, Altumira is specially designed to meet the demanding needs of digital radiography for both dynamic and static X-ray. At ECR, the full suite of industry-leading image enhancement products for ultrasound will be showcased. ContextVision's products deliver unsurpassed image quality for all types of ultrasound systems from handheld devices to the most advanced 3D/4D applications.
Read More